Semiconductor designer Advanced Micro Devices Inc (AMD) said on Tuesday it would buy Xilinx Inc in a $35 billion all-stock deal, intensifying its battle with Intel Corp in the data center chip market.
News-Medical.Net on MSN
Scalable synthetic biology revolutionizes targeted therapy with logic-gate proteins
Targeted drug delivery is a powerful and promising area of medicine. Therapies that pinpoint the exact areas of the body ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results